These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6245569)

  • 61. Effects of PGI2 and PGI analogues on cAMP levels in cultured endothelial and smooth muscle cells derived from bovine arteries.
    Dembinska-Kiec A; Rücker W; Schönhöfer PS
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):67-70. PubMed ID: 6154247
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of prostacyclin on intestinal ion transport in the rat.
    Hardcastle J; Hardcastle PT; Redfern JS
    Life Sci; 1980 Jan; 26(2):123-31. PubMed ID: 6245315
    [No Abstract]   [Full Text] [Related]  

  • 63. Oscillation of cyclic AMP with the heart cycle of the canine myocardium in situ.
    Krause EG; Bartel S; Freier W; Warbanow W; Gerber K; Ludecke J; Obst D
    Biomed Biochim Acta; 1986; 45(1-2):S205-10. PubMed ID: 3008710
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Current state of our knowledge about prostaglandins].
    Markov KhM
    Patol Fiziol Eksp Ter; 1979; (5):3-15. PubMed ID: 228228
    [No Abstract]   [Full Text] [Related]  

  • 65. PGI2 and PGD2 effects on cyclic AMP and human T-cell mitogenesis.
    Burchiel SW
    Prostaglandins Med; 1979 Nov; 3(5):315-20. PubMed ID: 233036
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of prostaglandin E1, I2 and isoproterenol on the tissue cyclic AMP content in longitudinal muscle of rabbit intestine.
    Nakahata N; Suzuki T
    Prostaglandins; 1981 Aug; 22(2):159-65. PubMed ID: 6270741
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prostaglandins and cyclic nucleotides in hypoxic myocardium.
    Vapaatalo H; Metsä-Ketelä T; Laustiola K
    Acta Med Scand Suppl; 1980; 642():66-78. PubMed ID: 6257056
    [No Abstract]   [Full Text] [Related]  

  • 68. Prostacyclin: a potent coronary dilating agent in the rat isolated heart [proceedings].
    Link HB; Rösen R; Schrör K
    J Physiol; 1978 Nov; 284():106P-107P. PubMed ID: 366105
    [No Abstract]   [Full Text] [Related]  

  • 69. Blood pressure and cardiac tissue responses to prostacyclin (PGI2) in various species.
    Collins GA; MacLeod BA; Walker MJ
    Can J Physiol Pharmacol; 1982 Feb; 60(2):134-9. PubMed ID: 6282426
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The action of the dihydro derivatives of prostacyclin--(6R)-PGI1 and (6S)-PGI1 on the heart and the coronary vasculature.
    Schrör K
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):213-7. PubMed ID: 381947
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of the potencies of some prostaglandins as vasodilators in three vascular beds of the anaesthetised dog.
    Lumley P; Humphrey PP; Kennedy I; Coleman RA
    Eur J Pharmacol; 1982 Jul; 81(3):421-30. PubMed ID: 6749531
    [TBL] [Abstract][Full Text] [Related]  

  • 72. PGI2 enhanced cAMP content in bovine coronary arteries in the presence of isobutylmethylxanthine.
    Dembinska-Kiec A; Rücker W; Schönhöfer PS
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):107-10. PubMed ID: 91976
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Effect of prostacyclin and 6-keto-PGFl alpha on coronary vascular resistance].
    Boroian RG
    Zh Eksp Klin Med; 1978; 18(4):40-4. PubMed ID: 360725
    [No Abstract]   [Full Text] [Related]  

  • 74. Prostaglandins of blood vessels and vessel reactivity in rats receiving sodium chloride and indomethacin.
    Nekrasova AA; Sokolova RN; Levitskaya Y; Speranskaya NV; Kulagina VP; Leghonkaya NP
    Adv Prostaglandin Thromboxane Res; 1980; 7():1139-43. PubMed ID: 6245566
    [No Abstract]   [Full Text] [Related]  

  • 75. Effects of prostacyclin on cardiovascular reflexes from the ventricular epicardium of the dog: comparison with the effects of prostaglandin E2.
    Staszewska-Barczak J; Dusting GJ; May DE; Nolan PN
    Prostaglandins; 1981 Jun; 21(6):905-15. PubMed ID: 7027322
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibitory action of intracoronary prostaglandin E 1 on myocardial lipolysis.
    Glaviano VV; Masters T
    Am J Physiol; 1971 May; 220(5):1187-93. PubMed ID: 4324937
    [No Abstract]   [Full Text] [Related]  

  • 77. Relationship between the prostaglandin system and responsiveness to epileptogenic agents in mature and immature rats.
    Paoletti R; Folco GC; Spagnuolo C; Terzi C
    Adv Prostaglandin Thromboxane Res; 1978; 4():191-8. PubMed ID: 206121
    [No Abstract]   [Full Text] [Related]  

  • 78. Effects of prostaglandins E1 and F1alpha on the heart-lung preparation of the dog.
    Katori M; Takeda K; Imai S
    Tohoku J Exp Med; 1970 May; 101(1):67-75. PubMed ID: 4988676
    [No Abstract]   [Full Text] [Related]  

  • 79. Cyclic nucleotide changes in human neutrophils induced by chemoattractants and chemotactic modulators.
    Hatch GE; Nichols WK; Hill HR
    J Immunol; 1977 Aug; 119(2):450-6. PubMed ID: 196022
    [No Abstract]   [Full Text] [Related]  

  • 80. Prevention of occlusive coronary artery thrombosis by prostacyclin infusion in the dog.
    Romson JL; Haack DW; Abrams GD; Lucchesi BR
    Circulation; 1981 Nov; 64(5):906-14. PubMed ID: 7026083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.